نتایج جستجو برای: pharmacogenetic

تعداد نتایج: 2484  

Journal: :Circulation 2007
Jeffrey L Anderson Benjamin D Horne Scott M Stevens Amanda S Grove Stephanie Barton Zachery P Nicholas Samera F S Kahn Heidi T May Kent M Samuelson Joseph B Muhlestein John F Carlquist

BACKGROUND Pharmacogenetic-guided dosing of warfarin is a promising application of "personalized medicine" but has not been adequately tested in randomized trials. METHODS AND RESULTS Consenting patients (n=206) being initiated on warfarin were randomized to pharmacogenetic-guided or standard dosing. Buccal swab DNA was genotyped for CYP2C9 *2 and CYP2C9 *3 and VKORC1C1173T with a rapid assay...

Journal: :Pharmacogenomics 2006
Anja Rogausch Daniela Prause Anne Schallenberg Jürgen Brockmöller Wolfgang Himmel

INTRODUCTION The integration of pharmacogenetic testing into routine care will, in part, depend upon the patients' and physicians' acceptance of these tests. Empirical data regarding patients' and physicians' views on pharmacogenetic testing are lacking. OBJECTIVES To explore patients' and physicians' perspectives on the potential implications of pharmacogenetic testing, particularly focusing...

2016
Anup Ojha Tanuj Joshi

Pharmacogenomics (constitute both branch i.e pharmacology and genetic) is the study of the role of genetics in drug response. It deals with the effect of genetic variation on drug response in patient by correlating the gene expression with the pharmacokinetic parameter i.e absorption, distribution metabolism and excreation. The Pharmacogenomics is used in the research to increase the safety and...

2016
Joseph Finkelstein Carol Friedman George Hripcsak Manuel Cabrera

Pharmacogenetic testing identifies genetic biomarkers that are predictive of individual sensitivity to particular drugs. A significant proportion of medications that are widely prescribed for older adults are metabolized by enzymes that are encoded by highly polymorphic genes. Pharmacogenetic testing is increasingly used to optimize the medication regimen; however, its potential in older adults...

Journal: :The Journal of molecular diagnostics : JMD 2016
Victoria M Pratt Robin E Everts Praful Aggarwal Brittany N Beyer Ulrich Broeckel Ruth Epstein-Baak Paul Hujsak Ruth Kornreich Jun Liao Rachel Lorier Stuart A Scott Chingying Huang Smith Lorraine H Toji Amy Turner Lisa V Kalman

Pharmacogenetic testing is increasingly available from clinical laboratories. However, only a limited number of quality control and other reference materials are currently available to support clinical testing. To address this need, the Centers for Disease Control and Prevention-based Genetic Testing Reference Material Coordination Program, in collaboration with members of the pharmacogenetic t...

Journal: :The Nurse Practitioner 2021

Journal: :Canadian Medical Association Journal 2010

Journal: :Journal of the American College of Cardiology 2012
Deepak Voora Geoffrey S Ginsburg

Pharmacogenetics primarily uses genetic variation to identify subgroups of patients who may respond differently to a certain medication. Since its first description, the field of pharmacogenetics has expanded to study a broad range of cardiovascular drugs and has become a mainstream research discipline. Three principle classes of pharmacogenetic markers have emerged: 1) pharmacokinetic; 2) phar...

2017
LAURA NUSSBAUM LAVINIA MARIA HOGEA DANIELA CĂLINA NICOLETA ANDREESCU RALUCA GRĂDINARU RADU ȘTEFĂNESCU MARIA PUIU

We approached the theme of modern pharmacological treatment strategies and the implication of pharmacogenetic testing in the management of child and adolescent psychoses. Our research was conducted in the period 2010 2015 on 210 patients, as follows: 150 children and adolescents with psychosis – a group of 75 children-G1, who benefited in choosing the pharmacotherapy from pharmacogenetic testin...

2017
Chad A. Bousman Malcolm Forbes Mahesh Jayaram Harris Eyre Charles F. Reynolds Michael Berk Malcolm Hopwood Chee Ng

About half of people who take antidepressants do not respond and many experience adverse effects. These detrimental outcomes are in part a result of the impact of an individual's genetic profile on pharmacokinetics and pharmcodynamics. If known and made available to clinicians, this could improve decision-making and antidepressant therapy outcomes. This has spurred the development of numerous p...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید